These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 24262798)

  • 21. Loss of alpha3/alpha4(IV) collagen from the glomerular basement membrane induces a strain-dependent isoform switch to alpha5alpha6(IV) collagen associated with longer renal survival in Col4a3-/- Alport mice.
    Kang JS; Wang XP; Miner JH; Morello R; Sado Y; Abrahamson DR; Borza DB
    J Am Soc Nephrol; 2006 Jul; 17(7):1962-9. PubMed ID: 16769745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Collagen type IV nephropathy: from thin basement membrane nephropathy to Alport syndrome].
    Endreffy E; Ondrik Z; Kemény E; Vas Z; Maróti Z; Lencse G; Bereczki C; Haszon I; Túri S; Iványi B
    Orv Hetil; 2005 Dec; 146(52):2647-53. PubMed ID: 16468607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinico-pathological correlations in 127 patients in 11 large pedigrees, segregating one of three heterozygous mutations in the COL4A3/ COL4A4 genes associated with familial haematuria and significant late progression to proteinuria and chronic kidney disease from focal segmental glomerulosclerosis.
    Pierides A; Voskarides K; Athanasiou Y; Ioannou K; Damianou L; Arsali M; Zavros M; Pierides M; Vargemezis V; Patsias C; Zouvani I; Elia A; Kyriacou K; Deltas C
    Nephrol Dial Transplant; 2009 Sep; 24(9):2721-9. PubMed ID: 19357112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular and functional characterization of urine-derived podocytes from patients with Alport syndrome.
    Iampietro C; Bellucci L; Arcolino FO; Arigoni M; Alessandri L; Gomez Y; Papadimitriou E; Calogero RA; Cocchi E; Van Den Heuvel L; Levtchenko E; Bussolati B
    J Pathol; 2020 Sep; 252(1):88-100. PubMed ID: 32652570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel heterozygous COL4A3 mutation in a family with late-onset ESRD.
    Hoefele J; Lange-Sperandio B; Ruessmann D; Glöckner-Pagel J; Alberer M; Benz MR; Nagel M; Weber LT
    Pediatr Nephrol; 2010 Aug; 25(8):1539-42. PubMed ID: 20177710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Co-Inheritance of Functional Podocin Variants with Heterozygous Collagen IV Mutations Predisposes to Renal Failure.
    Stefanou C; Pieri M; Savva I; Georgiou G; Pierides A; Voskarides K; Deltas C
    Nephron; 2015; 130(3):200-12. PubMed ID: 26138234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathogenicity of a Human Laminin
    Funk SD; Bayer RH; Malone AF; McKee KK; Yurchenco PD; Miner JH
    J Am Soc Nephrol; 2018 Mar; 29(3):949-960. PubMed ID: 29263159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of the BMP antagonist USAG-1 ameliorates disease in a mouse model of the progressive hereditary kidney disease Alport syndrome.
    Tanaka M; Asada M; Higashi AY; Nakamura J; Oguchi A; Tomita M; Yamada S; Asada N; Takase M; Okuda T; Kawachi H; Economides AN; Robertson E; Takahashi S; Sakurai T; Goldschmeding R; Muso E; Fukatsu A; Kita T; Yanagita M
    J Clin Invest; 2010 Mar; 120(3):768-77. PubMed ID: 20197625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic reprogramming with stem cells regenerates glomerular epithelial podocytes in Alport syndrome.
    LeBleu VS; Kanasaki K; Lovisa S; Alge JL; Kim J; Chen Y; Teng Y; Gerami-Naini B; Sugimoto H; Kato N; Revuelta I; Grau N; Sleeman JP; Taduri G; Kizu A; Rafii S; Hochedlinger K; Quaggin SE; Kalluri R
    Life Sci Alliance; 2024 Jun; 7(6):. PubMed ID: 38561223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How to resolve confusion in the clinical setting for the diagnosis of heterozygous COL4A3 or COL4A4 gene variants? Discussion and suggestions from nephrologists.
    Imafuku A; Nozu K; Sawa N; Nakanishi K; Ubara Y
    Clin Exp Nephrol; 2020 Aug; 24(8):651-656. PubMed ID: 32232700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Familial hematuria: A review.
    Plevová P; Gut J; Janda J
    Medicina (Kaunas); 2017; 53(1):1-10. PubMed ID: 28236514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preemptive ramipril therapy delays renal failure and reduces renal fibrosis in COL4A3-knockout mice with Alport syndrome.
    Gross O; Beirowski B; Koepke ML; Kuck J; Reiner M; Addicks K; Smyth N; Schulze-Lohoff E; Weber M
    Kidney Int; 2003 Feb; 63(2):438-46. PubMed ID: 12631109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thin basement membrane nephropathy.
    Savige J; Rana K; Tonna S; Buzza M; Dagher H; Wang YY
    Kidney Int; 2003 Oct; 64(4):1169-78. PubMed ID: 12969134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Laminin compensation in collagen alpha3(IV) knockout (Alport) glomeruli contributes to permeability defects.
    Abrahamson DR; Isom K; Roach E; Stroganova L; Zelenchuk A; Miner JH; St John PL
    J Am Soc Nephrol; 2007 Sep; 18(9):2465-72. PubMed ID: 17699809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Three Novel Heterozygous COL4A4 Mutations Result in Three Different Collagen Type IV Kidney Disease Phenotypes.
    Li A; Gao EZ; Cui YX; Liu JH; Lv X; Wei XX; Xia XY; Gao CL; Liu FX; Xia ZK; Asan ; Liu ZH; Li XJ
    Cytogenet Genome Res; 2018; 154(1):30-36. PubMed ID: 29669314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. COL4A3 founder mutations in Greek-Cypriot families with thin basement membrane nephropathy and focal segmental glomerulosclerosis dating from around 18th century.
    Voskarides K; Patsias C; Pierides A; Deltas C
    Genet Test; 2008 Jun; 12(2):273-8. PubMed ID: 18439107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phenotype variability in a large Spanish family with Alport syndrome associated with novel mutations in COL4A3 gene.
    Cervera-Acedo C; Coloma A; Huarte-Loza E; Sierra-Carpio M; Domínguez-Garrido E
    BMC Nephrol; 2017 Oct; 18(1):325. PubMed ID: 29089023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COL4A3/COL4A4 mutations producing focal segmental glomerulosclerosis and renal failure in thin basement membrane nephropathy.
    Voskarides K; Damianou L; Neocleous V; Zouvani I; Christodoulidou S; Hadjiconstantinou V; Ioannou K; Athanasiou Y; Patsias C; Alexopoulos E; Pierides A; Kyriacou K; Deltas C
    J Am Soc Nephrol; 2007 Nov; 18(11):3004-16. PubMed ID: 17942953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synaptopodin deficiency exacerbates kidney disease in a mouse model of Alport syndrome.
    Ning L; Suleiman HY; Miner JH
    Am J Physiol Renal Physiol; 2021 Jul; 321(1):F12-F25. PubMed ID: 34029143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cellular origins of type IV collagen networks in developing glomeruli.
    Abrahamson DR; Hudson BG; Stroganova L; Borza DB; St John PL
    J Am Soc Nephrol; 2009 Jul; 20(7):1471-9. PubMed ID: 19423686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.